These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 8450227)
1. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression. Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227 [TBL] [Abstract][Full Text] [Related]
2. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. Maier T; Holda JH; Claman HN J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774 [TBL] [Abstract][Full Text] [Related]
3. Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action. Shand FL Immunology; 1976 Dec; 31(6):943-51. PubMed ID: 11181 [TBL] [Abstract][Full Text] [Related]
4. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena. Holda JH; Maier T; Claman HN J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767 [TBL] [Abstract][Full Text] [Related]
5. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo. Shand FL Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325 [TBL] [Abstract][Full Text] [Related]
6. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma. Maier T; Holda JH J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798 [TBL] [Abstract][Full Text] [Related]
7. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression. Ishikawa H; Saito K; Kubota E J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225 [TBL] [Abstract][Full Text] [Related]
8. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805 [TBL] [Abstract][Full Text] [Related]
9. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183 [TBL] [Abstract][Full Text] [Related]
10. Abrogation of the lethal graft-vs.-host reaction developed to non-H-2 antigens: involvement of T suppressor cells distinct from veto cells. Halle-Pannenko O; Pritchard LL; Bruley-Rosset M Eur J Immunol; 1987 Dec; 17(12):1751-5. PubMed ID: 2961574 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease. McMaster R; Levy JG J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891 [TBL] [Abstract][Full Text] [Related]
13. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens. Polisson RP; Shearer GM J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production. Klimpel GR; Annable CR; Cleveland MG; Jerrells TR; Patterson JC J Immunol; 1990 Jan; 144(1):84-93. PubMed ID: 2104894 [TBL] [Abstract][Full Text] [Related]
15. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses. Hurtenbach U; Shearer GM J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057 [TBL] [Abstract][Full Text] [Related]
16. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential. Ishikawa H; Kubota E; Saito K J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314 [TBL] [Abstract][Full Text] [Related]
17. Ly and Ia phenotype of suppressor T cells induced by graft-vs.-host reaction. Shand FL Eur J Immunol; 1977 Oct; 7(10):746-8. PubMed ID: 73466 [TBL] [Abstract][Full Text] [Related]
18. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF). Yonkosky D; Buffett RF; Bennett M J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease. Cleveland MG; Annable CR; Klimpel GR J Immunol; 1988 Nov; 141(10):3349-56. PubMed ID: 3141498 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Ghayur T; Seemayer TA; Lapp WS Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]